LU76150A1 - - Google Patents

Info

Publication number
LU76150A1
LU76150A1 LU76150A LU76150A LU76150A1 LU 76150 A1 LU76150 A1 LU 76150A1 LU 76150 A LU76150 A LU 76150A LU 76150 A LU76150 A LU 76150A LU 76150 A1 LU76150 A1 LU 76150A1
Authority
LU
Luxembourg
Application number
LU76150A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to LU76150A priority Critical patent/LU76150A1/xx
Priority to NL7712100A priority patent/NL7712100A/xx
Priority to FR7733216A priority patent/FR2369841A1/fr
Priority to DE19772749318 priority patent/DE2749318A1/de
Priority to ZA00776645A priority patent/ZA776645B/xx
Priority to AU30418/77A priority patent/AU3041877A/en
Priority to BE182381A priority patent/BE860526A/fr
Priority to IL53318A priority patent/IL53318A0/xx
Priority to JP13316577A priority patent/JPS5359035A/ja
Publication of LU76150A1 publication Critical patent/LU76150A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LU76150A 1976-11-08 1976-11-08 LU76150A1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
LU76150A LU76150A1 (fr) 1976-11-08 1976-11-08
NL7712100A NL7712100A (nl) 1976-11-08 1977-11-02 Farmaceutische preparaten.
FR7733216A FR2369841A1 (fr) 1976-11-08 1977-11-04 Preparations pharmaceutiques contenant un derive de propanol et un tranquillisant mineur
DE19772749318 DE2749318A1 (de) 1976-11-08 1977-11-04 Pharmazeutische praeparate
ZA00776645A ZA776645B (en) 1976-11-08 1977-11-07 Pharmaceutical preparations
AU30418/77A AU3041877A (en) 1976-11-08 1977-11-07 Benzodiazepine - propanol derivative compositions
BE182381A BE860526A (fr) 1976-11-08 1977-11-07 Preparations pharmaceutiques contenant un derive de propanol et un tranquilisant mineur
IL53318A IL53318A0 (en) 1976-11-08 1977-11-07 Novel pharmaceutical preparations for treating tension and anxiety states comprising phenoxy propanol amines
JP13316577A JPS5359035A (en) 1976-11-08 1977-11-08 Medical composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU76150A LU76150A1 (fr) 1976-11-08 1976-11-08

Publications (1)

Publication Number Publication Date
LU76150A1 true LU76150A1 (fr) 1978-07-10

Family

ID=19728406

Family Applications (1)

Application Number Title Priority Date Filing Date
LU76150A LU76150A1 (fr) 1976-11-08 1976-11-08

Country Status (9)

Country Link
JP (1) JPS5359035A (fr)
AU (1) AU3041877A (fr)
BE (1) BE860526A (fr)
DE (1) DE2749318A1 (fr)
FR (1) FR2369841A1 (fr)
IL (1) IL53318A0 (fr)
LU (1) LU76150A1 (fr)
NL (1) NL7712100A (fr)
ZA (1) ZA776645B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468391A (en) * 1982-06-25 1984-08-28 Ayerst, Mckenna & Harrison, Inc. Combination of β-adrenoceptor antagonists and anxiolytic agents
JPS6124516A (ja) * 1984-07-12 1986-02-03 Fujisawa Pharmaceut Co Ltd 持続性錠剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1919342A1 (de) * 1969-04-16 1970-12-03 Boehringer Sohn Ingelheim Herzwirksame Kombinationspraeparate

Also Published As

Publication number Publication date
JPS5359035A (en) 1978-05-27
FR2369841A1 (fr) 1978-06-02
BE860526A (fr) 1978-05-08
AU3041877A (en) 1979-05-17
ZA776645B (en) 1978-08-30
NL7712100A (nl) 1978-05-10
DE2749318A1 (de) 1978-05-11
IL53318A0 (en) 1978-01-31

Similar Documents

Publication Publication Date Title
CH637798GA3 (fr)
FR2353240B1 (fr)
JPS551295B2 (fr)
CH629926GA3 (fr)
FR2374365B1 (fr)
JPS5330175U (fr)
JPS5320866U (fr)
JPS5542288B2 (fr)
JPS5637966B2 (fr)
JPS52113211U (fr)
JPS52129716U (fr)
JPS52156280U (fr)
JPS5624066Y2 (fr)
CS177800B1 (fr)
CS175528B1 (fr)
JPS5386004U (fr)
JPS5376213U (fr)
CH606873A5 (fr)
BE851241A (fr)
CH601079A5 (fr)
DD124617A5 (fr)
CH604860A5 (fr)
CH602330A5 (fr)
LU76150A1 (fr)
DD124827A1 (fr)